Amarin Corp PLC Equity-NMS: AMRN

Healthcare

Drug Manufacturers-General

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$1.16

52W high :

$2.23

1Y :

-19.46%

5Y :

-65.47%

Shares O/S :

98.8 M

Market cap :

115.6 M

What is the share price of Amarin Corp PLC today?

Amarin Corp PLC (AMRN) share price as of May 31, 2023, is $1.17. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Amarin Corp PLC?

Yes, Indian Investors can invest in the Amarin Corp PLC (AMRN) Share by opening an international trading account with Angel One.

How can I purchase Amarin Corp PLC shares in India?

Purchasing Amarin Corp PLC (AMRN) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Amarin Corp PLC (AMRN) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Amarin Corp PLC?

Yes, you can purchase fractional shares of Amarin Corp PLC (AMRN) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Amarin Corp PLC?

The market capitalization of Amarin Corp PLC on May 31, 2023, is $115.6 M.

In which sector Amarin Corp PLC belongs?

Amarin Corp PLC operates in the Healthcare sector, specifically in the Drug Manufacturers-General industry.

What documents are required to invest in Amarin Corp PLC stocks?

In order to invest in Amarin Corp PLC (AMRN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.